Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of adjuvant immunomodulatory agents for treatment of severe influenza
David S.C. Hui, Nelson Lee, Paul K.S. Chan, et al.
Antiviral Research (2018) Vol. 150, pp. 202-216
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Anja Strangfeld, Martin Schäfer, Milena Gianfrancesco, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 7, pp. 930-942
Open Access | Times Cited: 634
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, et al.
The Lancet (2021) Vol. 397, Iss. 10274, pp. 605-612
Open Access | Times Cited: 534
Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment
Jiajia Chen, Chenxia Hu, Lijun Chen, et al.
Engineering (2020) Vol. 6, Iss. 10, pp. 1153-1161
Open Access | Times Cited: 238
Influenza virus-related critical illness: prevention, diagnosis, treatment
Eric J. Chow, Joshua Doyle, Timothy M. Uyeki
Critical Care (2019) Vol. 23, Iss. 1
Open Access | Times Cited: 180
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100719-100719
Open Access | Times Cited: 172
Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference
John H. Beigel, Hannah Nam, Peter L. Adams, et al.
Antiviral Research (2019) Vol. 167, pp. 45-67
Open Access | Times Cited: 166
The Predictive Role of Systemic Inflammation Response Index (SIRI) in the Prognosis of Stroke Patients
Yihui Zhang, Zekun Xing, Kecheng Zhou, et al.
Clinical Interventions in Aging (2021) Vol. Volume 16, pp. 1997-2007
Open Access | Times Cited: 161
Host-directed immunotherapy of viral and bacterial infections: past, present and future
Robert S. Wallis, Anne O’Garra, Alan Sher, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 121-133
Open Access | Times Cited: 158
Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection
Yeming Wang, Guohui Fan, Alex P. Salam, et al.
The Journal of Infectious Diseases (2019) Vol. 221, Iss. 10, pp. 1688-1698
Open Access | Times Cited: 148
The role of currently used medicinal plants in aquaculture and their action mechanisms: A review
Dawit Adisu Tadese, Changyou Song, Cunxin Sun, et al.
Reviews in Aquaculture (2021) Vol. 14, Iss. 2, pp. 816-847
Closed Access | Times Cited: 138
Influenza infection, SARS, MERS and COVID-19: Cytokine storm – The common denominator and the lessons to be learned
Varvara A. Ryabkova, Leonid P. Churilov, Yehuda Shoenfeld
Clinical Immunology (2020) Vol. 223, pp. 108652-108652
Open Access | Times Cited: 137
Immunosuppressive Drugs and COVID-19: A Review
Tessa S. Schoot, Angèle P. M. Kerckhoffs, Luuk B. Hilbrands, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 113
Severe Acute Lung Injury Related to COVID‐19 Infection: A Review and the Possible Role for Escin
Luca Gallelli, Leiming Zhang, Tian Wang, et al.
The Journal of Clinical Pharmacology (2020) Vol. 60, Iss. 7, pp. 815-825
Open Access | Times Cited: 102
Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial
John H. Beigel, Evgenia Aga, Marie‐Carmelle Elie‐Turenne, et al.
The Lancet Respiratory Medicine (2019) Vol. 7, Iss. 11, pp. 941-950
Open Access | Times Cited: 100
Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature
Andreas Hensel, Rudolf Bauer, Michael Heinrich, et al.
Planta Medica (2020) Vol. 86, Iss. 10, pp. 659-664
Open Access | Times Cited: 97
Plant-Derived Nutraceuticals and Immune System Modulation: An Evidence-Based Overview
Antonella Di Sotto, Annabella Vitalone, Silvia Di Giacomo
Vaccines (2020) Vol. 8, Iss. 3, pp. 468-468
Open Access | Times Cited: 96
Influenza antivirals and their role in pandemic preparedness
Jeremy C. Jones, Hui‐Ling Yen, Peter Adams, et al.
Antiviral Research (2022) Vol. 210, pp. 105499-105499
Open Access | Times Cited: 50
Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection
Yeming Wang, Qiang Guo, Zheng Yan, et al.
The Journal of Infectious Diseases (2018) Vol. 217, Iss. 11, pp. 1708-1717
Open Access | Times Cited: 78
Influenza Infections and Emergent Viral Infections in Intensive Care Unit
Ben Cantan, Charles‐Édouard Luyt, Ignacio Martín‐Loeches
Seminars in Respiratory and Critical Care Medicine (2019) Vol. 40, Iss. 04, pp. 488-497
Open Access | Times Cited: 76
Readiness for Responding to a Severe Pandemic 100 Years After 1918
Barbara Jester, Timothy M. Uyeki, Daniel B. Jernigan
American Journal of Epidemiology (2018)
Open Access | Times Cited: 74
Characteristics and serological patterns of COVID‐19 convalescent plasma donors: optimal donors and timing of donation
Ling Li, Xunliang Tong, Hanwei Chen, et al.
Transfusion (2020) Vol. 60, Iss. 8, pp. 1765-1772
Open Access | Times Cited: 66
Confirmed Invasive Pulmonary Aspergillosis and COVID-19: the value of postmortem findings to support antemortem management
Monique Freire Santana, Guilherme Pivoto, Márcia Almeida Araújo Alexandre, et al.
Revista da Sociedade Brasileira de Medicina Tropical (2020) Vol. 53
Open Access | Times Cited: 65
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
Xiaosheng Liu, Wei Cao, Taisheng Li
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 64
The antiviral and immunomodulatory activities of propolis: An update and future perspectives for respiratory diseases
Andrea Magnavacca, Enrico Sangiovanni, Giorgio Racagni, et al.
Medicinal Research Reviews (2021) Vol. 42, Iss. 2, pp. 897-945
Open Access | Times Cited: 49
Prediction of poststroke cognitive impairment based on the systemic inflammatory response index
Min Chu, Yunhe Luo, Daosheng Wang, et al.
Brain and Behavior (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top